HUE034488T2 - Vérgyûjtõ eszköz sejtmentes plazma DNS stabilizálására - Google Patents

Vérgyûjtõ eszköz sejtmentes plazma DNS stabilizálására Download PDF

Info

Publication number
HUE034488T2
HUE034488T2 HUE13706856A HUE13706856A HUE034488T2 HU E034488 T2 HUE034488 T2 HU E034488T2 HU E13706856 A HUE13706856 A HU E13706856A HU E13706856 A HUE13706856 A HU E13706856A HU E034488 T2 HUE034488 T2 HU E034488T2
Authority
HU
Hungary
Prior art keywords
dna
sample
protective agent
agent composition
blood
Prior art date
Application number
HUE13706856A
Other languages
English (en)
Inventor
Wayne L Ryan
M Rohan Fernando
Kausik Das
Original Assignee
Streck Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47755032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE034488(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Streck Inc filed Critical Streck Inc
Publication of HUE034488T2 publication Critical patent/HUE034488T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Claims (3)

  1. vérgyűjtő «®»&ds say treetes pXassss WS áP»3>XXXsáláe4ra S t ab a da i y j, .1 g é by pen t 0 b I. dlgbsss, sestiy a kdsssbtesé ibgjéseket tartsbaatta; a V bieiégis·, sa.äitä siiibasgynfytbl tsrteiyiba történő aegkapá.sa, saeiy éa.rtslyar legalább agy kar.brge regíaantsa első nskielnsavas, aasiy iába olyan sgyetípdi, areiy tarts Írassa at égyás baját ggkivaia.aavát, ebes ea ggyéáCgt a kgtatksggk körül sydiasstg e.k : bíb:ssöeigé:ráány áldösá ta , ikiltéteierett. âi.kcaatây at egyed rákos állapot aetektáiásán és/sagy yonitorodssán begy ksrexsstüi, at egyek nesrodegenerat1e állagéi: detektálásán és/vagy eon itcsr ötáaáe. ïtegy kereáttdl. át egyed p e s:i c Pi à t a 2 ab. á 11 a p o t de t sis t: á i á s át; é s / v a g y t:a a i tote t á s â a P e g y k -a :e e s s g g y, yagy agy ner terhes egyed; P, :essiab:t extig a eds begyűjtő t értéi y ban va a, a biclégiái stints érintksaaetéee egy vsdôeser kèatiitsénnyei, eaeiy tartositéaaert, ae:t i keiigaï.àrsiP: . sa egy kielte ate':·: ta y: taira a egy eiyan elegy kepségelia :; , sanely tartsiskryss; s sbebblsser késői lisésy:: bei s edssiái; és egy olyan rsakeietaradk kbipaose, a;aeb.y: Ci; a bioXdybsi arasa ssdaLeirrsavása né ave inert; bee (il; team:es xtiaatiseabieie aiobérbitői; ágy, iiogy a :seLrtában lété nebele ires yak alkalssrak a goiraerát iânereakeiôra es DNS staRtarbiáara a itloiâ lac;yaa:ttása nélkül legs-iább i nagea ât de a Dde sentes alsehid által indáikéit fi) taikleb.teaa - iaPé?:js te reá ti: kötési: 61,· 11 a 1 nxekl;yi:eee.v an k bed as a v 1 at :t axto le tu i ár b, a é e i tág y i a t: e r sol t: ka 1 ár is kt: r e e s b. kbit é se. k t P1, ta g y aies Ci) f sosed Ci à i --sbl , àgy, nagy at esetied ibslesiéye saaseab b or a a idehidstt kieltjgi: a k laites serrel a végesgee kbess ItaéniybbiX, aael a vsKels ts: ·; kêssitviêny tarte.iss a legaládb egy tartbesi laie sert a köyebketbb·: kord 1 val as s tes : dia se 11 bit 1 i - kerbayig, Paiessolidi as 1~ ka rkay lg, dies soileb,---i, S--:bie;e t lin i .dar it crat, d iaat .1 ici "bearbaei a, t-'-brér-é; , -r i g rogrepdn - 1, Ci-· dies, se: s s .a si d i a 5; y, ri t. r i sa - b s dir ox i e a t i 1. - g i 1 e i. a a t:, s - ini d rot 1 set s t i set .11 - 1 -1 e. s a " 3, b - a i o t: a b .1 c s k i o Çi Cl, k, 0 C ok ta s;, g -hi e r s r sets t i i -1 - i as a - 3, 7 ai y, ses b s e i r i a Ç 1,3,0 Ç aktán, ;5--bsd.rc:K:lgeii bi:s:ti 1 anses Ci :::6::11--1--18.2,::1--3, Igiosagiei blob; 3,3 , OJ eé.gárp kraterner adaeisntin, vagy esek káryslyás: iessgb.xrseb.ggá . .¾ Ää 1. Xsbbiypcssb: tap;: i ax i aX syxásí, isb;xl sa; is) Xéasa asiSipibssss barbel;;:®: iS s· s ί'- visa; y vX saras t?xi;x ta ;sa g ki$ passât χ,ϊχΡόΧ a aeiPaX , sagt & xs à skie set kè s £ i £.ïî:â an y a 1 é rX η : : ke a t a s s si a,
  2. 3. Isa 1, isgasypobt: aeetXbt;. sl;;éd‘à:ïg sxbaX at PtXbk kssatexéi; .Lépést XLsipbsaa taxa.bs.Xj S: sasiba ainx késs s:b;aaáby késs:. bay äs® k és* tsíntisiv ssXkis Xiasiils sí Sí S. , ssias Xy txírkaXSiis s: i a. i:S Idádé.3. S.sk:iSt:1 il.--sta.;tS:>SS ü.:.tSxjt: k;akssrn:âi b assr kiest kbrdkbaXiíl ö, I kbaik;b&amp;sül lf0 tdxaasl ss'eeayiaéxshiax a xekjae kbsaisakaayae abase; b. sápét: ;sastbi;:a éti X'érssilSïÎListtebrascetsa'Siat asst ikeagaiinxakiS;t kibsalbssáaL 0,0.5 - kbrxXriaslPi 0,7 5 tösesgá assnb.yliiágbéd &amp; S:ei:lass késsáxxaéayas ásássá; si a s:, k.keltbsáert isit? es si à sás Seíásiy áíségbis:; dabés, begy béxikiXyéa asadssa foréséldébiddeX xa;xgàl. lût. SsixaLy et taXaiS sxîXXdiaiX kasbastidboi sasbsabas Se.1 y xaddibabtis xskivk bPpaêaàb&amp;a, amely seer boss setae i ni. y gXoldgXâ:® essnsa sssxixaeXy tthes j bi Sava k dasas t axáXésséhoa.. b ke 1. Xgllaypeixt aaertatX sslplaasy absl a;s èrinbkest.ptee iSspâta nagábas: aagbaXjs eédXixiEdï' kéas.bxxséirykbbt alyass aie; s; it rats; y ai ksiasa aibnlt, amely tas s :;;ày.aa bike; si bal iS;. 10 käss-agra;;;; msisayXssgbsà;'; keaee x váibéásré kerb. lise lai ! ; : ; bâti g a é s a K i o i t é s a a r ;; e ;s à· s s? e, 5; jár: 1, issksbyactb; äSEssrintl ailâtsls, saak se éxXat keaskstés Xéssée® eagébér; seglalja kX<::d xsiaeax kéat eXysa vagyaiét alkib.;tsrbs-:ét:, isrseXy tarbirkra;; Xeyslbab assy ely::;;:: fsaskctás; assopariaá.,· saasly képed <á xexkáirxdeax.xi élekttobkiáayiJi; tar;beáss cksspaxsa: j sva I s:sagél as... é;X ixkiaXye;: a k didst késs őkéé i:iS:s ibsliéatb gsspbib:pbX ask basSstuísb; bssi ísvasSyűie·:, ssxasXy a s: arias kdehXddel seagslxys tayai. Xcskk ésaivbgy :b::X:o bab i: f-básisít képei;, Tag y egy aiysa ssXxyyrXxal saEgyiXl a x:. sasáa.ly a bsxaiis ideal dael reagálva “i isi i bsa; asset ált kép.*®, a, ist i, :; pisa y pass;: kserlnti. eljárás, aha.l a a ssssLsitbiieiasSsea Xápéesa assábsss iíiasiis 1 js; iíiPXtcsisasirkéfsS: aXySEi iáss;;Estaao ::sX;;:a.X;;s:iiaa:S;;, siaäiXyst. a bâisei.kiSaàk kbiasli sála s bbtt b : isst:; iü.asise;s b, isikl.Läiislaak, paliamlboà, prlner astiaak, sseabsibiies; asssiaaky asaataie:;;; sab, aagy esek ka;tSsXaáviój;i, 7. bas X. XgPbÿpsitt sïbatiak:; aXjà.::iis, abel a a ér iisi- ks as atba i sspêsa sssasgábisa XcgsbaXps bi-i.si:ciaï;î; r akat aXyi;i: assssaatS'ye ssiska iitssa;kaábí iiaaiyat a kísesss k-stoK këaüX aâXaaatssakî alisslr:;, iiaka, asaXbisdtasiX:;;, sasxu a::.;::, ka airaalcb ssdasrivsy gasissie, a ks g a x ssp tXsstxn, sspaiatisikt, xsagy atisb by.xss;:; 1 yen kaisblasvc: idja. δ. Pa I- igO-r ypor-t s serire: i eljárási- ara,! át. ériétpaytesás .lépése- «rsgéPar-íárgiaija s- ssaéés terskái.ááhic: reagálta Sását Sert.:, lel . -isiin eahiitt Pia áss , Sahst: 0'-"basis Riőilái kei esst kötett reásoiótsrbék, Sarki fi-bá sis bít-er- vagy ® s e k b árts i 1 y ses R seb i aà s J. 61 á n a k k é s a 5- s: ë s a. a. lis 1. raàr.ypers a Sa ?: raté eljárás- ahaJ. a hsát. té?: gesse rkes PRP esJ.rpje a aJ.atât ás vèdéssart. Part, alita se tartálysa-s keeese-bp; «skgt -snsak a Parker gânosdktrs ;ib*---ast a seiakjo- aeaijy eétyiggeyt gab, baas:?; esak s? -pkrstit i: s r e a J. -"ses 6 k s? r t á I yp a π s a s;, a e j ® .1 es - 1 ö - Ä Os igèaypoat asaaiata eljárás- .-iíi-eJ.p ira ri: aléas sa a rs.-rtár tsrtaJrsssá aerptâiy ápvipeiát egy sieb helyről. egy sásodik helyre- ahel -as ésvrtaèrvrk legalább egy résre e-sigsaaPP- sarat 0 *2 hér-artéksetet tärkPaih, 11. Ä. 2. egér vassal sses: inkái eljárás:, ehet a kioltás; as; érért testa:-: és lépese elést ssrtéaé.K:, 12. P 2, rgéaypeat sasi rá SÍ ti eág érés, ascO. a kioltás as árJ.:atkastetás lépesével egyitia j úiv-g tőt Párták. 12. A 1. igéhypcat sse-r.irii eljárás, ahol as eljárás a "pata sersrif-PU- aerate társié iásás nass 1 arialítassa, lé. A 4. igé.sypőxik ssériât 1 eljárás- -Pisi as elegy ;seates as olyas; eP-teásé Járató kovassas aPek;asi:a;rektöl - a-telyek eráialják a Osp is-roli ál k.áesPt a pellt-eraa Res.Ppes és eiaagásiá gátsásévar., a printer iralegités gáiléaával, e-alvsay s ebé lessek j.rierkaiácsájásak gátlásával, 11, és 1, Pgártypoai: star set J. e.l járás- atal a kittláe- star kcb-cástráclá j g. a alapa ás t-it restates lépését kOvetsea aagy-tk-P- adat ö-2-)l gkel, s:agyPPb- sriat 2,202 g/irl vagy rag éagyobb, apát 0,204 g/lsl a vsdesses' és a adata eJ.pgyare nerve- 10, ás 1. rganypcq-: sagipaal eljárás, ahel, g k pal id; gser ksbvoerdrrágpí j a a s-rats etpprkssPpP-e lépeséi: kölessse kisebb, eJ.rrl 2,03 gpal, kisebb- sast 0, 21 g/ap.- vagy bég kisebb, -tini 0-022 g/as a eédsasrar ás a binká elegyáre sás ve-. 1:2, é.4. 1 gáoypsst gsarpe: 1 el járás- ar;ai a vásásser r-agábaa ro-jJ.al koPPks-sO.i 1 lona-ga-tál kárOibeJátl 12 te;".agjs-'le -vrsjeáa a-et-tyieéebsíá kioltó staart. Iá. ;1 4. igiisotpoavo .statist! «1 járás;, ahol -a ogopasoa: raaghasar; foglal ISshlbelöl 1 Söísoág%~toi xíVrh 1 bőiül oá tc™&amp;g.%~í.q isrjocio :sío:oí:; vü.oogp®·'; EDTa-ío Iáä 4. Iqbráypoot ssstlááoi iülyárá.s, ásol 3 Ssololiásór svágaOsáí foglal iogaláíso kl:o: iiiüisöi sl 1 só ás ikOsóoáöbb, Óvást iitt ál bőiül la Ság kioltó sássr t:,
  3. 21, Is 1, Ig'ááaypcááo:: ssoriaski ollasias. SiáOÜ. as O.ixgiy sioato« g szobáid aloololdtől ;íC OSE";:sl Sááátvo, 11. oo 1. líáfsaypoáit ssorint! ollaráag adói as ology fuss oütaü iosfsasot a Ιοί ö pg:S ksttiáísányiOSO sJg ISIS-tó i. SáétSO .· llo ás 1. oyanypOái: sas ai sül 0.11 ittas f aooi.y Stytábád fog!alga oáXtosé ásásai saadsas Issbatüdibiéioas (VTáR; soldas gálát lépôsâoox sálsikiaését as oleyyOío 21 >. iá 4 . 1 gaosy'goáiS ssarlpg;;. sljárát, a.hol a obübosOr ta^iSáia.ag. dläsolidi tál·· ids ffcasudgtfOilba sói.1 iái iái 1 boa Sátlsidiat ás EDl'á-d;, 11, iá. :. : : ον ο V á aaa a á o ai ka iss. sása á: a á o. i : á :· S,áíVsg s.yOi; ypsssi: itso:t ;.y a i olyasai; iógstáíáotogliáshaoi .
HUE13706856A 2012-02-13 2013-02-13 Vérgyûjtõ eszköz sejtmentes plazma DNS stabilizálására HUE034488T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261597908P 2012-02-13 2012-02-13
US201261671681P 2012-07-14 2012-07-14

Publications (1)

Publication Number Publication Date
HUE034488T2 true HUE034488T2 (hu) 2018-02-28

Family

ID=47755032

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13706856A HUE034488T2 (hu) 2012-02-13 2013-02-13 Vérgyûjtõ eszköz sejtmentes plazma DNS stabilizálására

Country Status (9)

Country Link
US (3) US20140080112A1 (hu)
EP (3) EP3225699B1 (hu)
DE (1) DE202013012535U1 (hu)
DK (2) DK3225699T3 (hu)
HU (1) HUE034488T2 (hu)
PL (1) PL2814981T3 (hu)
PT (1) PT2814981T (hu)
SI (1) SI2814981T1 (hu)
WO (1) WO2013123030A2 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003254755B2 (en) 2002-10-16 2007-12-20 Streck, Inc. Method and device for collecting and preserving cells for analysis
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
DK2398912T3 (en) 2009-02-18 2017-10-30 Streck Inc Conservation of cell-free nucleic acids
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
EP2721140B1 (en) 2011-06-19 2016-11-23 Abogen, Inc. Devices, solutions and methods for sample collection
DK3225699T3 (da) 2012-02-13 2020-12-21 Streck Inc Blodopsamlingsanordning til forbedret nukleinsyreregulering
US10988803B2 (en) * 2014-12-29 2021-04-27 Life Genetics Lab, Llc Multiplexed assay for quantitating and assessing integrity of cell-free DNA in biological fluids for cancer diagnosis, prognosis and surveillance
AU2014233373B2 (en) 2013-03-15 2019-10-24 Verinata Health, Inc. Generating cell-free DNA libraries directly from blood
EP3024323B1 (en) 2013-07-24 2022-10-19 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
US20170198335A1 (en) * 2014-06-10 2017-07-13 Biomatrica, Inc. Stabilization of Non-Denatured Polypeptides, Nucleic Acids, and Exosomes in a Blood Sample at Ambient Temperatures
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
FI4035762T3 (fi) 2015-09-09 2023-12-04 Drawbridge Health Inc Laitteita näytteiden keräämistä, stabilointia ja säilytystä varten
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2017201612A1 (en) * 2016-05-27 2017-11-30 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
KR20240036152A (ko) 2017-01-10 2024-03-19 드로브릿지 헬스, 인크. 샘플 수집을 위한 장치, 시스템, 및 방법
CN106900692A (zh) * 2017-03-06 2017-06-30 上海迅伯生物科技有限公司 一种血液dna的保存剂组合物
WO2019005833A1 (en) * 2017-06-26 2019-01-03 Mendoza Estevan SAMPLE FILTERING DEVICE
CN107267500A (zh) * 2017-07-17 2017-10-20 北京安必奇生物科技有限公司 一种游离dna保存液及其制备方法和应用
PL3662080T3 (pl) 2017-08-02 2022-04-19 Sarstedt Ag & Co. Kg Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek
CN109055353A (zh) * 2018-07-17 2018-12-21 无锡百泰克生物技术有限公司 一种血液游离dna的保护剂
DE102018218739B3 (de) 2018-11-01 2020-03-19 Sarstedt Ag & Co. Kg Blutentnahmeröhre und Verfahren zur Präparation
USD920534S1 (en) 2018-12-21 2021-05-25 CanaryQ, Inc. Blood sample filtration device
WO2020140035A1 (en) * 2018-12-27 2020-07-02 Streck, Inc. Methods of preparing samples for proteomic analysis
CN111808842B (zh) * 2019-09-18 2022-03-01 简石生物技术(北京)有限公司 一种核酸保护试剂及其使用方法
JPWO2021177344A1 (hu) 2020-03-05 2021-09-10
CN113109473B (zh) * 2021-04-13 2022-01-14 长沙晨辰医药科技有限公司 一种甲醛衍生测试方法
KR20240046683A (ko) 2021-08-25 2024-04-09 세키스이 메디칼 가부시키가이샤 세포 함유액용 보존액 및 세포 함유액용 보존 용기
IL293203A (en) * 2022-05-22 2023-12-01 Nucleix Ltd Preparation of samples for cell-free DNA analysis
IL293202A (en) 2022-05-22 2023-12-01 Nucleix Ltd Useful combinations of restriction enzymes
WO2024092158A1 (en) * 2022-10-27 2024-05-02 Microgenics Corporation Stabilization of nucleic acids in body fluids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201865B (en) * 1989-04-28 1991-01-28 Pecsi Dohanygyar Tobacco-smoke filter of high efficiency
US5849517A (en) * 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
US6072086A (en) * 1996-04-12 2000-06-06 Intergen Company Method and composition for controlling formaldehyde fixation by delayed quenching
DE602005023646D1 (de) * 2004-12-10 2010-10-28 Siemens Healthcare Diagnostics Für die vorhersage des ansprechens maligner neoplasie auf eine auf taxan beruhende medizinische behandlung geeignete genetische veränderung
ES2264403B1 (es) * 2006-06-22 2007-11-01 Grifols S.A. Medio de suspension de hematies.
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8537789B2 (en) 2007-08-01 2013-09-17 Harris Corporation Mobile ad-hoc network providing communication latency reduction features and related methods
US20100167271A1 (en) * 2008-12-30 2010-07-01 Streck, Inc. Method for screening blood using a preservative that may be in a substantially solid state form
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
DK2398912T3 (en) * 2009-02-18 2017-10-30 Streck Inc Conservation of cell-free nucleic acids
US20110027771A1 (en) * 2009-07-31 2011-02-03 Artemis Health, Inc. Methods and compositions for cell stabilization
DK3225699T3 (da) 2012-02-13 2020-12-21 Streck Inc Blodopsamlingsanordning til forbedret nukleinsyreregulering

Also Published As

Publication number Publication date
DK3225699T3 (da) 2020-12-21
EP3789499B1 (en) 2023-03-15
EP3225699A1 (en) 2017-10-04
WO2013123030A3 (en) 2013-10-31
EP3225699B1 (en) 2020-09-30
DK2814981T3 (en) 2017-10-16
EP3789499A1 (en) 2021-03-10
PT2814981T (pt) 2017-10-03
US20140080112A1 (en) 2014-03-20
EP2814981B1 (en) 2017-06-28
US20240026340A1 (en) 2024-01-25
PL2814981T3 (pl) 2017-12-29
SI2814981T1 (sl) 2017-11-30
WO2013123030A2 (en) 2013-08-22
US20200255819A1 (en) 2020-08-13
EP2814981B2 (en) 2021-04-28
EP2814981A2 (en) 2014-12-24
DE202013012535U1 (de) 2017-08-28

Similar Documents

Publication Publication Date Title
US20240026340A1 (en) Blood collection device for improved nucleic acid regulation
JP5711887B2 (ja) 短いタンデム反復遺伝子座の多重増幅
Greenspoon et al. QIAamp spin columns as a method of DNA isolation for forensic casework
Mulero et al. Development and validation of the AmpFℓSTR® MiniFilerTM PCR Amplification Kit: a miniSTR multiplex for the analysis of degraded and/or PCR inhibited DNA
US20050244879A1 (en) Multiplex amplification of short tandem repeat loci
AU2012236880B2 (en) Telomere length measurement in formalin-fixed, paraffin embedded (FFPE) samples by quantitative PCR
JP2014155504A (ja) ショートタンデムリピート遺伝子座のマルチプレックス増幅のための方法およびキット
EP2640848A1 (en) Methods and kits for multiplex amplification of short tandem repeat loci
JP2007509613A (ja) 遺伝子発現プロファイリングのためのｑＲＴ−ＰＣＲアッセイシステム
JP2023116700A (ja) 主要組織適合遺伝子複合体一塩基多型
Uchiyama et al. Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion group
Hsiao Sources of error in molecular diagnostic analyses
Lee et al. A rapid nuclear staining test using cationic dyes contributes to efficient STR analysis of telogen hair roots
CN109312397B (zh) Penta E基因座多态性人体鉴定
Tie et al. Detection of deletion/insertion polymorphism profiles from single human hair shafts
Nakahara et al. Heteroplasmies detected in an amplified mitochondrial DNA control region from a small amount of template
Dash et al. Fast, High-Sensitive, and High-Resolution DNA Techniques
US20200087708A1 (en) System and method for isolation and qualification of nucleic acids
Jabbar et al. Detection of Copy Number of Mitochondrial DNA in Iraq Population.
Zou et al. Standard Chromosome Analyses–Karyotyping
Thompson An Analysis of Efficiency and Melt Curve Effects on Quantitative Polymerase Chain Reaction (qPCR) Inhibition
VIRAY Implementation of Applied Biosystems AmpFlSTR® MiniFiler™ Amplification Kit For Forensic Casework: Validation, Inhibition, and Contact DNA Studies
Mai Application of SCODA to forensic exhibits
Conneally et al. Molecular Forensic Pathology